Last Updated: September 24, 2026

HALOTHANE Drug Patent Profile

Name: HALOTHANE Drug Patent, Exclusivity, and Generic Launch Dataset
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

✉ Email this page to a colleague

« Back to Dashboard

Which patents cover Halothane, and when can generic versions of Halothane launch?

Halothane is a drug marketed by BH, Halocarbon, and Hospira. and is included in three NDAs.

The generic ingredient in HALOTHANE is halothane. There is one drug master file entry for this compound. Additional details are available on the halothane profile page.

AI Deep Research

Questions you can ask:

What is the 5 year forecast for HALOTHANE?
What are the global sales for HALOTHANE?
What is Average Wholesale Price for HALOTHANE?

Summary for HALOTHANE

US Patents:	0
Applicants:	3
NDAs:	3
Raw Ingredient (Bulk) Api Vendors:	61
Clinical Trials:	14
Patent Applications:	4,337
DailyMed Link:	HALOTHANE at DailyMed

Drug patent expirations by year for HALOTHANE

Recent Clinical Trials for HALOTHANE

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Zagazig University	NA
Benha University	NA
Cairo University	Phase 1/Phase 2

See all HALOTHANE clinical trials

Medical Subject Heading (MeSH) Categories for HALOTHANE

Anesthetics, Inhalation

Anatomical Therapeutic Chemical (ATC) Classes for HALOTHANE

N01AB	Halogenated hydrocarbons
N01A	ANESTHETICS, GENERAL
N01	ANESTHETICS
N	Nervous system

US Patents and Regulatory Information for HALOTHANE

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Bh	HALOTHANE	halothane	LIQUID;INHALATION	084977-001	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Halocarbon	HALOTHANE	halothane	LIQUID;INHALATION	080810-001	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Hospira	HALOTHANE	halothane	LIQUID;INHALATION	083254-001	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.